Last Updated: May 10, 2026

Suppliers and packagers for AMINOCAPROIC ACID IN PLASTIC CONTAINER


✉ Email this page to a colleague

« Back to Dashboard


AMINOCAPROIC ACID IN PLASTIC CONTAINER

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Hospira AMINOCAPROIC ACID IN PLASTIC CONTAINER aminocaproic acid INJECTABLE;INJECTION 070010 ANDA Henry Schein, Inc. 0404-9812-20 1 VIAL, SINGLE-DOSE in 1 BAG (0404-9812-20) / 20 mL in 1 VIAL, SINGLE-DOSE 2021-10-26
Hospira AMINOCAPROIC ACID IN PLASTIC CONTAINER aminocaproic acid INJECTABLE;INJECTION 070010 ANDA Hospira, Inc. 0409-4346-73 25 VIAL, SINGLE-DOSE in 1 TRAY (0409-4346-73) / 20 mL in 1 VIAL, SINGLE-DOSE (0409-4346-16) 2010-05-12
Hospira AMINOCAPROIC ACID IN PLASTIC CONTAINER aminocaproic acid INJECTABLE;INJECTION 070010 ANDA Medical Purchasing Solutions, LLC 71872-7359-1 1 VIAL, SINGLE-DOSE in 1 BAG (71872-7359-1) / 20 mL in 1 VIAL, SINGLE-DOSE 2010-05-12
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers for Aminocaproic Acid in Plastic Containers

Last updated: April 24, 2026

Aminocaproic acid (“ACA”) is supplied by multiple global manufacturers in commercial packaging that can include plastic containers (most commonly HDPE bottles, sometimes with desiccant and/or induction seals depending on grade and region). Supply is split across two practical channels: (1) pharmaceutical-grade API makers that sell bulk drug substance to branded formulators and (2) finished-dose manufacturers and distributors that supply plastic-bottled product into pharmacies.

Which suppliers sell aminocaproic acid in plastic containers?

Aminocaproic acid API suppliers (bulk drug substance that can be packaged into plastic for distribution)

The most direct sources for “aminocaproic acid” in plastic containers are API manufacturers and their distribution arms. Typical container formats for bulk and intermediate shipments include HDPE-lined containers or HDPE pails with liners, depending on grade and shipping mode.

Supplier list (global, commercial API presence):

  • Shanghai Yuanye Bio-Technology Co., Ltd. (aminocaproic acid catalog as chemical/API grade; packaging is commonly retail-grade plastic bottle formats for smaller pack sizes)
  • TCI Chemicals (Tokyo Chemical Industry) (aminocaproic acid catalog; standard chemical packaging uses plastic bottles for many SKUs)
  • Cayman Chemical (aminocaproic acid sold for research and lab use; packaging typically uses plastic bottles for standard catalog sizes)
  • Sigma-Aldrich / Merck KGaA (aminocaproic acid as a catalog chemical with plastic container formats in many regions)

These suppliers usually market for “chemical” or “research” grades rather than finished pharmaceutical packaging. For pharmaceutical-grade supply to regulated markets, the same manufacturers or their partners may offer GMP documentation, but container type and regulatory status vary by SKU.

Finished-dose suppliers/distributors (pharmacy product often in plastic)

For finished pharmaceutical use, aminocaproic acid is commonly dispensed in oral solid or oral liquid formats in markets where the product is authorized. Oral solid units are frequently supplied in HDPE bottles with child-resistant closures and tamper-evident induction seals.

Because authorization and presentation vary by geography, finished-dose “plastic container” supply is typically handled through regional wholesalers and product label holders rather than a single global API vendor list.

What “plastic container” formats are standard for aminocaproic acid products?

Common container types

  • HDPE bottles (most common for oral solids and many API/chemical SKUs)
  • Plastic pails/bags with liners (more common for bulk API; not always “bottle” but still plastic containerized)
  • Thermal-sealed sachets inside outer plastic bottles (some oral granule or compounded product workflows)

Typical packaging attributes

  • Tamper-evident induction seal on HDPE bottles (common in regulated retail distribution)
  • Child-resistant closures on prescription bottles (common in many jurisdictions)
  • Desiccant in bottles for moisture-sensitive grades (depends on specification and stability data)

Supplier selection criteria that determine whether the container is plastic (what matters in procurement)

1) Regulatory grade vs. catalog chemical

  • Pharmaceutical grade (API): requires GMP/DMF or equivalent documentation for regulated manufacturing
  • Chemical/research grade: usually relies on CoA and standard chemical packaging; still may ship in plastic

2) Pack size drives container choice

  • Small pack sizes (often grams to small kilograms) commonly ship in plastic bottles
  • Bulk packs (multiple kilograms to drum-scale) often ship in plastic pails/drums or paper bags in plastic liners

3) Region determines finished-dose packaging

  • A “plastic container” requirement for finished product depends on local market authorization and the label packaging used by the marketing authorization holder.

Actionable procurement path (how buyers typically source)

  1. If you need pharmaceutical-grade supply: buy aminocaproic acid from GMP-capable API manufacturers or their authorized distributors, and match your packaging requirement (plastic container) to the quoted pack format.
  2. If you need research/chemical-grade: use catalog suppliers; plastic bottles are the default container type for many SKUs.
  3. If you need ready-to-dispense product: source finished product through regional distributors/wholesalers aligned to the presentation you require (HDPE bottle dosing format).

Key Takeaways

  • Aminocaproic acid is supplied by multiple global catalog and chemical suppliers that commonly package in plastic bottles (often HDPE) for standard pack sizes.
  • Pharmaceutical-grade supply to regulated manufacturing typically comes from GMP-capable API suppliers with packaging determined by pack size and distribution channel.
  • Finished-dose “plastic container” supply is region- and authorization-dependent, and procurement usually runs through regional wholesalers or the marketing authorization holder.
  • When specifying “in plastic containers,” procurement must tie the requirement to grade (pharma vs chemical), pack size, and the SKU presentation.

FAQs

1) Are aminocaproic acid suppliers usually packaging in HDPE bottles?
For many retail chemical and small-pack commercial SKUs, yes. HDPE bottles are a common default container format.

2) Can I source aminocaproic acid in pharmaceutical-grade packaging from the same suppliers that sell research grade?
Sometimes through specific GMP-enabled SKUs or authorized channels, but container type and regulatory documentation vary by product line.

3) Do API suppliers ship aminocaproic acid in plastic containers for bulk orders?
Bulk shipments are often containerized in plastic pails or plastic-lined packaging systems depending on pack size and shipping mode.

4) Does “plastic container” apply to finished-dose aminocaproic acid tablets/liquids too?
Often yes for oral solid prescriptions (commonly HDPE bottles), but packaging format depends on the authorized product presentation in each market.

5) What affects whether the supplier can meet a “plastic container” requirement?
The specific SKU, grade (GMP vs catalog), pack size, closure style, and whether the supplier’s compliance packaging system is fixed for that product.


References

[1] TCI Chemicals. “Aminocaproic Acid” (product catalog page).
[2] Cayman Chemical. “Aminocaproic Acid” (product listing).
[3] Merck/Sigma-Aldrich. “Aminocaproic Acid” (product page).
[4] Shanghai Yuanye Bio-Technology Co., Ltd. “Aminocaproic Acid” (product listing).

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.